Montesinos, Pau ;
Roboz, Gail J ;
Bulabois, Claude Eric...
Montesinos , P , Roboz , G J , Bulabois , C E , Subklewe , M , Platzbecker , U , Ofran , Y , Papayannidis , C , Wierzbowska , A , Shin , H J , Doronin , V , Deneberg , S , Yeh , S P , Ozcan , M A , Knapper , S , Cortes , J , Pollyea , D A , Ossenkoppele , G , Giralt , S , Döhner , H , Heuser , M , Xiu , L , Singh , I , Huang , F , Larsen , J S & Wei , A H 2021 , ' Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy : results from a multicenter, randomized, phase 2/3 study ' , Leukemia , vol. 35 , no. 1 , pp. 62-74 . https://doi.org/10.1038/s41375-020-0773-5.
,
2021